Entrada Therapeutics (TRDA) Receivables - Net (2023 - 2026)
Entrada Therapeutics (TRDA) recorded Receivables - Net of $816,000 in Q2 2026, down 30.8% from $1.18 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Receivables - Net (2023 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics reported Receivables - Net of $1.18 million, down 68.0% from FY2024.
- Across earlier years, Receivables - Net came in at $3.68 million in FY2024 (-37.4%) and $5.88 million in FY2023.
- Quarterly Receivables - Net has ranged from $787,000 in Q1 2026 to $77.51 million in Q1 2024 over the past five years.
- On a year-over-year basis, Receivables - Net has declined for eight consecutive quarters, with an average decline of 60.2% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 105.0% in Q2 2024, against a decline of 97.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $787,000 (Q1 2026), $1.18 million (Q4 2025) and $1.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn |
| 10 | Entrada Therapeutics | 205.20 Mn | -154.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 816,000.00 |
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 77.51 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 3.74 Mn |
| Mar 31, 2023 | 6.30 Mn |
API Access
Entrada Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();